Answer
Ogsiveo (nirogacestat dihydrobromide) is a reversible, non-competitive inhibitor of gamma secretase that blocks proteolytic activation of the Notch receptor.
Sources for this answer
- Ogsiveo 150 mg film coated tabletsMerck · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked